HEATHER WADE: Open Payments
NPI 1235464652 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,702 in 46 payments from 17 companies in 2025. Trend: 2023 $2,032 · 2024 $1,415 · 2025 $1,702
Food & beverage: $1,702
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $304 |
| Amgen Inc. | 7 | $210 |
| CVRx, Inc. | 2 | $184 |
| Ancora Heart, Inc. | 1 | $155 |
| Novartis Pharmaceuticals Corporation | 8 | $147 |
| Merck Sharp & Dohme LLC | 7 | $140 |
| Lilly USA, LLC | 2 | $121 |
| Alnylam Pharmaceuticals Inc. | 3 | $93 |
| ABIOMED | 3 | $70 |
| Actelion Pharmaceuticals US, Inc. | 1 | $67 |
Products named: Rapiblyk, REPATHA, Barostim Neo System, AccuCinch, LEQVIO, ZEPBOUND, VERQUVO, ONPATTRO.
Industry payments across LA — which companies pay providers there.
